272 related articles for article (PubMed ID: 11851732)
1. Botulinum toxin type A management of spasticity in the context of orthopaedic surgery for children with spastic cerebral palsy.
Graham HK
Eur J Neurol; 2001 Nov; 8 Suppl 5():30-9. PubMed ID: 11851732
[TBL] [Abstract][Full Text] [Related]
2. Use of botulinum toxin A in management of children with cerebral palsy.
Friedman BC; Goldman RD
Can Fam Physician; 2011 Sep; 57(9):1006-73. PubMed ID: 21918142
[TBL] [Abstract][Full Text] [Related]
3. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
Barrett RS
Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
[No Abstract] [Full Text] [Related]
4. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A for spastic cerebral palsy: Is it time to change praxis?
Colovic H; Dimitrijevic L; Stankovic I; Radovic-Janosevic D; Zlatanovic D
J Rehabil Med; 2020 Feb; 52(2):. PubMed ID: 31922204
[TBL] [Abstract][Full Text] [Related]
8. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
[TBL] [Abstract][Full Text] [Related]
11. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].
Kurenkov AL; Klochkova OA; Bursagova BI; Karimova HM; Kuzenkova LM; Mamedyarov AM; Namazova-Baranova LS; Agranovich OV; Agranovich AO; Soboleva OA; Khapaeva MM; Batysheva TT; Sarzhina MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):37-44. PubMed ID: 29265085
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option.
Kirschner J; Berweck S; Mall V; Korinthenberg R; Heinen F
J Neurol; 2001 Apr; 248 Suppl 1():28-30. PubMed ID: 11357236
[TBL] [Abstract][Full Text] [Related]
14. Facts and de facto treatment of spasticity.
Kim H; Stanford R
J Pediatr Rehabil Med; 2020; 13(2):189-193. PubMed ID: 32568127
[TBL] [Abstract][Full Text] [Related]
15. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications.
Autti-Rämö I; Larsen A; Taimo A; von Wendt L
Eur J Neurol; 2001 Nov; 8 Suppl 5():136-44. PubMed ID: 11851742
[TBL] [Abstract][Full Text] [Related]
16. Management of children with ambulatory cerebral palsy: an evidence-based review.
Narayanan UG
J Pediatr Orthop; 2012 Sep; 32 Suppl 2():S172-81. PubMed ID: 22890458
[TBL] [Abstract][Full Text] [Related]
17. Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.
Placzek R; Siebold D; Funk JF
Toxins (Basel); 2010 Sep; 2(9):2258-71. PubMed ID: 22069684
[TBL] [Abstract][Full Text] [Related]
18. Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: preliminary report.
Suputtitada A
Am J Phys Med Rehabil; 2000; 79(4):320-6. PubMed ID: 10892617
[TBL] [Abstract][Full Text] [Related]
19. The effects of botulinum toxin (BTX-A) on spasticity of the lower limb and on gait in cerebral palsy.
Preiss RA; Condie DN; Rowley DI; Graham HK
J Bone Joint Surg Br; 2003 Sep; 85(7):943-8. PubMed ID: 14516023
[No Abstract] [Full Text] [Related]
20. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
